Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APAF1 | O14727 | 2/20 | 0.57 |
| ▸ | IDO1 | P14902 | 15/20 | 0.54 |
| ▸ | TDO2 | P48775 | 12/20 | 0.47 |
| ▸ | IDO2 | Q6ZQW0 | 10/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | MITF | O75030 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.39 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4586346 | 0.82 | APAF1 (0.60) | APAF1IDO1TDO2IDO2EGFR | |
| SCHEMBL9233005 | 0.81 | APAF1 (0.58) | APAF1IDO1TDO2IDO2EGFR | |
| SCHEMBL11904697 | 0.81 | APAF1 (0.60) | APAF1IDO1TDO2IDO2EGFR | |
| SCHEMBL9235681 | 0.78 | APAF1 (0.56) | APAF1IDO1TDO2IDO2EGFR | |
| SCHEMBL26614118 | 0.78 | APAF1 (0.61) | APAF1IDO1TDO2IDO2EGFR | |
| SCHEMBL30639091 | 0.78 | APAF1 (0.61) | APAF1IDO1TDO2IDO2EGFR | |
| SCHEMBL4585839 | 0.77 | APAF1 (0.51) | APAF1IDO1TDO2IDO2EGFR | |
| SCHEMBL9105478 | 0.77 | APAF1 (0.57) | APAF1IDO1TDO2IDO2EGFR | |
| SCHEMBL26858212 | 0.76 | TDO2 (0.70) | APAF1IDO1TDO2IDO2EGFR | |
| SCHEMBL4587834 | 0.76 | APAF1 (0.47) | APAF1IDO1TDO2IDO2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1594524-B1 | USE OF TRYPTANTHRIN COMPOUNDS FOR IMMUNE POTENTIATION | NOVARTIS VACCINES & DIAGNOSTIC (US) | 2012-08-15 | — | — | EP | claimed |
| EP-1594524-A4 | USE OF TRYPTANTHRIN COMPOUNDS FOR IMMUNE POTENTIATION | NOVARTIS VACCINES & DIAGNOSTIC (US) | 2008-09-03 | — | — | EP | claimed |
| EP-1594524-A2 | USE OF TRYPTANTHRIN COMPOUNDS FOR IMMUNE POTENTIATION | CHIRON CORPORATION (US) | 2005-11-16 | — | — | EP | claimed |
| WO-2004064759-A2 | USE OF TRYPTANTHRIN COMPOUNDS FOR IMMUNE POTENTIATION | CHIRON CORPORATION (US) | 2004-08-05 | — | — | WO | claimed |
| EP-1594524-B1 | USE OF TRYPTANTHRIN COMPOUNDS FOR IMMUNE POTENTIATION | NOVARTIS VACCINES & DIAGNOSTIC (US) | 2012-08-15 | — | — | EP | disclosed |